The global apoptosis assays market share valued of USD 2.99 billion in 2017 and is expected to register a CAGR of 9.4% during the forecast period.
Increasing RD expenses and growing cell-based research are expected to drive the growth of the market. On the other hand, required high investment for research activities can restrain the market growth over the assessment period. Recently, in 2016, the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute received USD 5.1 million from the California Institute for Regenerative Medicine. This funding helps for the development of novel therapy for blinding retinal conditions. Furthermore, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017. This funding drives the growth of the apoptosis assays market.
Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and increasing funding for cell apoptosis assay. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market. Furthermore, the Middle Eastern and African region is expected to account for the least market share in the global market.
The global apoptosis assays market has been segmented into product, detection technology, application, and end user.
Based on product, the market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share and fastest growing segment of the global apoptosis assays market in 2017.
Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others. The flow cytometry segment accounted for the largest share segment of the global apoptosis assays market in 2017.
Based on application, the market has been segmented into drug discovery and development, stem cell research, and others. The drug discovery and development segment accounted for the largest share of the global apoptosis assays market in 2017. The stem cell research was the fastest growing segment of the global apoptosis assays market in 2017.
Based on end user, the market has been segmented into pharmaceutical and biological companies, research institutes, and others. The pharmaceutical and biological companies segment accounted for the largest share of the global apoptosis assays market in 2017. Research institutes were the fastest growing segment of the global apoptosis assays market in 2017.
Some of the prominent players in the global apoptosis assays market are Abcom plc (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071